By Michael J. Hyde, James A. Herrick
Technology, rhetoric, and conversing in regards to the post-human future.
Read or Download After the genome : a language for our biotechnological future PDF
Similar medical ethics books
In recent times, advantage theories have loved a renaissance of curiosity between common and scientific ethicists. This publication deals a virtue-based ethic for medication, the well-being professions, and wellbeing and fitness care. starting with a historic account of the idea that of advantage, the authors build a conception of where of the virtues in scientific perform.
How medical professionals imagine defines the character and value of scientific judgment. even if physicians utilize technology, this e-book argues that drugs isn't really itself a technological know-how yet fairly an interpretive perform that will depend on scientific reasoning. a doctor seems to be on the patient's heritage besides the proposing actual symptoms and juxtaposes those with medical event and empirical stories to build a tentative account of the sickness.
There's a range of ‘ethical practices’ inside of medication as an institutionalised occupation in addition to a necessity for moral experts either in perform in addition to in institutionalised roles. This short bargains a social point of view on scientific ethics schooling. It discusses a number of strategies suitable to academic concept and therefore presents a easy illumination of the topic.
Controlling Our Destinies provides the reflections of a world crew of students from a number of humanistic disciplines at the old origins, the philosophical content material, the moral matters, and the science-religion questions raised by means of the HGP. individuals comprise John Beatty, Robert Bud, Arthur Caplan, Alice Domurat Dreger, Kevin Fitzgerald, Jean-Paul Gaudillière, Jean Gayon, Marguerite Hays, Lily Kay, Evelyn Fox Keller, Philip Kitcher, Timothy Lenoir, Richard McCormick, Ernan McMullin, Edward Manier, Timothy Murphy, John Opitz, Diane Paul, Arthur Peacocke, Martin Pernick, Hans Jörg Rheinberger, Kenneth Schaffner, Phillip R.
- Arguing About Bioethics
- From Justice to Protection: A Proposal for Public Health Bioethics
- Verhältnismäßigkeit in der modernen Medizin: Von den außergewöhnlichen Mitteln zur Behandlungsqualität als personaler Abwägung (Erfurter Theologische Studien)
- Hippocratic, Religious, and Secular Medical Ethics: The Points of Conflict
- Beyond Humanity? The Ethics of Biomedical Enhancement
- Ethics, Sexual Orientation, and Choices about Children
Additional info for After the genome : a language for our biotechnological future
In their place, dangerous genetically engineered animals prey on surviving human populations. Amid this chaos, the only voices of sanity are those of a gentle quasi-religious community, God’s Gardeners, whose teachings and orations punctuate the novels. But these gentle people, along with most of the 41 42 g A fter the Genome human race, ultimately succumb to the “waterless flood,” a viral epidemic resulting from gene splicing gone awry. Between 1925 and 2009, the world turned upside down. Religion went from being a threat to scientific advance to the sole bastion of human feeling in a world of technocratic domination.
In one stroke, the era of Edward R. Murrow, Walter Cronkite, Eric Sevareid, Ed Bradley, and Daniel Schorr came to an end, replaced by a new competitive marketplace. instead of intensifying the quest for understanding, these changes forced news programs into financial competition with entertainment, offering a new forum for extreme, outlier, and controversial opinions.
And here some additional nonmedical factors are likely to come into play. Because health insurance reimbursement is provided only for medically indicated treatment and a small select category of preventive interventions, such as immunizations (primary prevention) and some diagnostic screening and testing (secondary prevention), unless the category of reimbursable preventive interventions expands considerably, patients and their doctors will prefer to change the point at which kidney disease is diagnosed in order to be assured that health insurers will provide them with financial access to earlier “treatment”—which then is not readily distinguishable from secondary prevention.